Kiniksa Pharmaceuticals Ltd. (KNSA)
20.35
-1.41 (-6.48%)
At close: Apr 04, 2025, 3:59 PM
20.36
0.05%
After-hours: Apr 04, 2025, 04:20 PM EDT
Kiniksa Pharmaceuticals Ltd. Revenue
Kiniksa Pharmaceuticals Ltd. reported an annual revenue of $423.24M, reflecting a 56.6% growth. For the quarter ending December 31, 2024, Kiniksa Pharmaceuticals Ltd. generated $122.54M in revenue.
Revenue (ttm)
$423.24M
Revenue Growth
56.6%
Price / Sales Ratio
3.34
Revenue / Employee
$1.34M
Employees
315
Market Cap
1.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 423.24M | +56.60% |
| Dec 31, 2023 | 270.26M | +22.74% |
| Dec 31, 2022 | 220.18M | +471.24% |
| Dec 31, 2021 | 38.54M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |